Daiichi Jitsugyo (DJA) is a sales and service distributor that was founded with...
DJA: ‘The Walmart of pharmaceutical’
Daiichi Jitsugyo (DJA) is a sales and service distributor that was founded with the sole aim of covering all the machines required by the pharmaceutical industry. We talk to Rusty Nelson, the company’s general manager and vice-president, to learn a bit more about the company and its history.
Maharshi: High-performance packaging and printing machines
Indian company Maharshi provides high-performance machines for labelling, printing, visual inspection and leak testing for a number of industries. In North America, its exclusive distributor is Daiichi Jitsugyo (DJA). We talk to DJA vice-president Rusty Nelson about these specialist machines and what sets his company apart from others in the field.
Can blockchain stem the tide of counterfeit drugs in India?
Counterfeit drugs are a multi-billion dollar problem. Now pharma companies are looking for a technological solution, could blockchain be the answer?
Monomaterial Packaging Benefits
In February 2108, a young sperm whale washed up on a beach in southeastern Spain. When scientists carried out a necropsy, they discovered the huge mammal had succumbed to a fatal infection caused by more than 30 kilos of plastics in its stomach and intestines.
Ebola in the DRC: vaccinating in a conflict zone
Attempts to control the Ebola outbreak in the north-eastern Democratic Republic of Congo have been hindered by ongoing conflict in the area. While Merck’s experimental Ebola vaccine was on the ground within a week of the outbreak being declared, violence and instability in the region is testing the limits of the supply and the effectiveness on vaccination strategies.
Future NASH reimbursement issues may echo HCV therapies
Nonalcoholic steatohepatitis (NASH) therapies with prospective launches post-2020 will likely have reimbursement challenges mirroring those faced by hepatitis C (HCV) therapies approved five years ago, experts said.
Are you a manufacturer, importer, distributor or wholesaler of healthcare products? RAQAC has the specialised knowledge to help you navigate the Canadian regulatory requirements for registering and marketing products.
Four new Pfizer brands will help make up for looming Lyrica patent expiry
Pfizer is gearing up to commercialise its four new brands as quickly as they were approved in order to build up new revenue that will offset the impending revenue loss as the generic versions start to eat away the market share of Lyrica next year.
Uncertainty drives negative Brexit sentiment in healthcare
The Brexit process has a long way to go, as a vote of approval from the UK Parliament, which is expected to occur in December 2018, is still needed for the deal to go forward.
Industry experts believe External Reference Pricing is coming to the US
External Reference Pricing is the practice of using the price of a product in foreign countries to derive a benchmark for setting or negotiating the price of a product within a specific country.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.